Table 4.
Significant associated factors for the complete recovery of cardiovascular autonomic neuropathy in subjects with type 2 diabetes
| Complete recovery (n = 9) | ||||||
|---|---|---|---|---|---|---|
| Univariate OR (95% CI) | P value | Adjusted OR (95% CI)a | P value | Adjusted OR (95% CI)b | P value | |
| Baseline variables | ||||||
| Younger age (per 5-year decrease) | 1.67 (1.26–2.20) | < 0.001 | 1.63 (1.07–2.49) | 0.023 | 1.67 (1.26–2.23) | < 0.001 |
| Total cholesterol (per 10 mg/dL decrease) | 1.27 (0.97–1.67) | 0.088 | 1.24 (0.96–1.61) | 0.099 | ||
| HbA1c (per 1% decrease) | 0.97 (0.94–1.00) | 0.065 | 1.54 (0.78–3.05) | 0.212 | ||
| Change in variables | ||||||
| Δ Change in oral anti-diabetes drug, yes | 4.94 (1.02–23.94) | 0.047 | 3.44 (0.65–18.07) | 0.145 | ||
| Δ Change in anti-hypertensive drug, yes | 0.10 (0.02–0.52) | 0.006 | 0.96 (0.84–10.91) | 0.971 | ||
aOnly factors with P < 0.10 on univariate logistic regression were presented and included in the multivariate logistic regression
bOdd ratios were analyzed by a forward–backward stepwise selection process